Trial Profile

A study to investigate CB1

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 25 May 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs CB 1 (Primary)
Indications Breast cancer
Focus Adverse reactions

Most Recent Events

19 May 2016 The Company is preparing the IND package with the intention of progressing to clinical trials this year, according to a Tiziana Life Sciences media release.
28 Jan 2016 New trial record
08 Jan 2016 The company intends to file an IND application on CB1 in 2016, and expects to move this drug candidate into clinical trials before the end of the year, according to a Tiziana Life Sciences media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com